These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1. Casslén B; Sandberg T; Gustavsson B; Willén R; Nilbert M Biol Reprod; 1998 Jun; 58(6):1343-50. PubMed ID: 9623591 [TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
24. IL-1alpha is a potent stimulator of keratinocyte tissue plasminogen activator expression and regulated by TGF-beta1. Lian X; Yang L; Gao Q; Yang T Arch Dermatol Res; 2008 Apr; 300(4):185-93. PubMed ID: 18204848 [TBL] [Abstract][Full Text] [Related]
25. Modulated expression of plasminogen activator system components in cultured cells from dissociated mouse dorsal root ganglia. Hayden SM; Seeds NW J Neurosci; 1996 Apr; 16(7):2307-17. PubMed ID: 8601810 [TBL] [Abstract][Full Text] [Related]
26. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis. Xue W; Hashimoto K; Toi Y J Cutan Pathol; 1998 Oct; 25(9):469-74. PubMed ID: 9821076 [TBL] [Abstract][Full Text] [Related]
27. Comparison of CD163+ CD206+ M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid. Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Aiba S Dermatology; 2014; 229(4):369-78. PubMed ID: 25401296 [TBL] [Abstract][Full Text] [Related]
28. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Busso N; Péclat V; So A; Sappino AP Ann Rheum Dis; 1997 Sep; 56(9):550-7. PubMed ID: 9370880 [TBL] [Abstract][Full Text] [Related]
29. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts. Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005 [TBL] [Abstract][Full Text] [Related]
30. A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey-Hailey disease-like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene. Iino Y; Kano T; Adachi F; Suzuki M; Nishikawa R; Ishii N; Ohata C; Furumura M; Hamada T; Hashimoto T J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1646-8. PubMed ID: 24750354 [No Abstract] [Full Text] [Related]
31. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076 [TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680 [TBL] [Abstract][Full Text] [Related]
33. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1. Keski-Oja J; Koli K J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632 [TBL] [Abstract][Full Text] [Related]
34. Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis. Lyons-Giordano B; Loskutoff D; Chen CS; Lazarus G; Keeton M; Jensen PJ Histochemistry; 1994 Feb; 101(2):105-12. PubMed ID: 8071082 [TBL] [Abstract][Full Text] [Related]
38. Expression and regulation of plasminogen activators, plasminogen activator inhibitor type-1, and steroidogenic acute regulatory protein in the rhesus monkey corpus luteum. Liu K; Feng Q; Gao HJ; Hu ZY; Zou RJ; Li YC; Liu YX Endocrinology; 2003 Aug; 144(8):3611-7. PubMed ID: 12865343 [TBL] [Abstract][Full Text] [Related]
39. Disruption of the cytoskeleton-extracellular matrix linkage promotes the accumulation of plasminogen activators in F9 derived parietal endoderm. Snyder RW; Lenburg ME; Seebaum AT; Grabel LB Differentiation; 1992 Aug; 50(3):153-62. PubMed ID: 1330791 [TBL] [Abstract][Full Text] [Related]
40. Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoid. Gissler HM; Simon MM; Kramer MD Br J Dermatol; 1992 Sep; 127(3):272-7. PubMed ID: 1390172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]